格拉德斯通投资 GAIN 深 沪
已收盘 10-31 16:00:00 美东时间
13.82
-0.010
-0.07%
华盛通- 最 高14.04
- 今 开13.89
- 成交量 15.75万股
- 最 低 13.80
- 昨 收 13.83
- 总市值 5.10亿
- 52周最高 14.40
- 市盈率 静 7.77
- 换手率 0.43%
- 52周最低 10.32
- 委 比 83.68%
- 总股本 3692.12万
- 历史最高 14.40
- 量 比 0.99
- 振 幅 1.74%
- 历史最低 -7.836
- 每 手 1
- 风险率 0.87%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Gary Shilling Warns Gen Z: 'Young People Are Going To Have To Work A Lot Harder Than They Might Think To Succeed' In AI Era
Economist Gary Shilling warns of AI's impact on jobs & wealth. Hustle, adaptability, & AI skills are key for success, experts say.
10-26 13:34
Gain Therapeutics to Attend the 2025 Maxim Growth Summit
Gain Therapeutics, Inc. will participate in the 2025 Maxim Growth Summit on October 22-23 at The Hard Rock Hotel NYC. Gene Mack, President and CEO, will join a panel discussion on innovative approaches for neurogenerative diseases in clinical trials. Gain is a clinical-stage biotech company developing next-generation allosteric small molecule therapies for neurodegenerative diseases, rare genetic disorders, and oncology. Its lead candidate, GT-02...
10-16 11:00
Gladstone Investment declares $0.08 dividend
Gladstone Investment (NASDAQ:GAIN) declared $0.08/share monthly dividend, in line with previous. Payable Oct. 31; for shareholders of record Oct. 24; ex-div Oct. 24. Payable Nov. 26; for shareholders ...
10-15 04:12
东海研究 | 电子：中美科技摩擦升级，OpenAI将部署6GW AMD GPU算力
（来源：东海研究） 证券分析师： 方霁，执业证书编号：S0630523060001 联系人： 董经纬，邮箱：djwei@longone.com.cn ...
10-14 14:46
中美AI芯片杀疯了！AMD叫板英伟达，寒武纪华为绑定DeepSeek绝地反击
（图片来源：SCMP） AI芯片已经成为中美科技竞争中的重要“王牌”。 过去半个多月，高达4.5万亿美元市值的英伟达宣布，未来十年将向OpenAI投资至多1...
10-13 08:31
芯片禁售!美国参议院一纸法案，反而点燃了A股科技股的激情?
（来源：财报翻译官） 10月9日，美国参议院不顾科技界反对，通过了《保障国家人工智能访问与创新法案》（GAIN AI），要求英伟达、AMD等先进AI芯片制造商...
10-11 09:16
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
Gain Therapeutics will host a virtual KOL event on October 14, 2025, at 4:00 p.m. EST, featuring experts Karl Kieburtz and Kenneth Marek. The event will discuss biomarkers, clinical endpoints, and data from GT-02287, a Phase 1b candidate for Parkinson’s disease. GT-02287 has shown favorable safety and trends of improvement in MDS-UPDRS scores. Preclinical data suggest potential disease-modifying effects. Registration for the event is available on...
10-09 11:00
Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson’s Patients at International Congress of Parkinson’s Disease and Movement Disorders®
<p>Gain Therapeutics reported positive early results from its Phase 1b study of GT-02287 for Parkinson's disease. Participants showed improvement in MDS-UPDRS scores, and the drug was well-tolerated with no serious adverse events. Plasma exposures were within therapeutic ranges. A virtual KOL event on October 14 will discuss the findings. Preclinical data suggest GT-02287 may slow disease progression by restoring GCase enzyme function and reducin...
10-06 12:15
Gain Therapeutics to Participate at Drug Discovery Innovation Programme 2025
Gain Therapeutics' Director of AI, Dr. Rinaldo Montalvão, will present at the WORLD BI DDIP 2025 conference in Barcelona on September 26. His talk, "Transforming Drug Discovery: Generative Models and Electrostatic Complementarity," will focus on AI and automation in drug discovery. Gain Therapeutics specializes in developing next-generation allosteric therapies, with its lead candidate GT-02287 in Phase 1b trials for Parkinson's disease. The comp...
09-23 11:40
特朗普新招：一场“集资式晚宴”
（来源：华山穹剑） 9月4日，特朗普在装修一新的白宫玫瑰园举办晚宴，邀请的是全美国据称“最聪明的人”——20多位科技巨头，他们包括Meta的扎克伯格、苹果的库克...
09-07 20:51
公司简介
公司名称
|
格拉德斯通投资
|
行业分类
|
资产管理
|
业务描述
|
Gladstone Investment is a publicly traded business development company that seeks to make equity and secured debt investments.
|
Gary Shilling Warns Gen Z: 'Young People Are Going To Have To Work A Lot Harder Than They Might Think To Succeed' In AI Era
Economist Gary Shilling warns of AI's impact on jobs & wealth. Hustle, adaptability, & AI skills are key for success, experts say.
10-26 13:34
Gain Therapeutics to Attend the 2025 Maxim Growth Summit
Gain Therapeutics, Inc. will participate in the 2025 Maxim Growth Summit on October 22-23 at The Hard Rock Hotel NYC. Gene Mack, President and CEO, will join a panel discussion on innovative approaches for neurogenerative diseases in clinical trials. Gain is a clinical-stage biotech company developing next-generation allosteric small molecule therapies for neurodegenerative diseases, rare genetic disorders, and oncology. Its lead candidate, GT-02...
10-16 11:00
Gladstone Investment declares $0.08 dividend
Gladstone Investment (NASDAQ:GAIN) declared $0.08/share monthly dividend, in line with previous. Payable Oct. 31; for shareholders of record Oct. 24; ex-div Oct. 24. Payable Nov. 26; for shareholders ...
10-15 04:12
东海研究 | 电子：中美科技摩擦升级，OpenAI将部署6GW AMD GPU算力
（来源：东海研究） 证券分析师： 方霁，执业证书编号：S0630523060001 联系人： 董经纬，邮箱：djwei@longone.com.cn ...
10-14 14:46
中美AI芯片杀疯了！AMD叫板英伟达，寒武纪华为绑定DeepSeek绝地反击
（图片来源：SCMP） AI芯片已经成为中美科技竞争中的重要“王牌”。 过去半个多月，高达4.5万亿美元市值的英伟达宣布，未来十年将向OpenAI投资至多1...
10-13 08:31
芯片禁售!美国参议院一纸法案，反而点燃了A股科技股的激情?
（来源：财报翻译官） 10月9日，美国参议院不顾科技界反对，通过了《保障国家人工智能访问与创新法案》（GAIN AI），要求英伟达、AMD等先进AI芯片制造商...
10-11 09:16
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
Gain Therapeutics will host a virtual KOL event on October 14, 2025, at 4:00 p.m. EST, featuring experts Karl Kieburtz and Kenneth Marek. The event will discuss biomarkers, clinical endpoints, and data from GT-02287, a Phase 1b candidate for Parkinson’s disease. GT-02287 has shown favorable safety and trends of improvement in MDS-UPDRS scores. Preclinical data suggest potential disease-modifying effects. Registration for the event is available on...
10-09 11:00
Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson’s Patients at International Congress of Parkinson’s Disease and Movement Disorders®
<p>Gain Therapeutics reported positive early results from its Phase 1b study of GT-02287 for Parkinson's disease. Participants showed improvement in MDS-UPDRS scores, and the drug was well-tolerated with no serious adverse events. Plasma exposures were within therapeutic ranges. A virtual KOL event on October 14 will discuss the findings. Preclinical data suggest GT-02287 may slow disease progression by restoring GCase enzyme function and reducin...
10-06 12:15
Gain Therapeutics to Participate at Drug Discovery Innovation Programme 2025
Gain Therapeutics' Director of AI, Dr. Rinaldo Montalvão, will present at the WORLD BI DDIP 2025 conference in Barcelona on September 26. His talk, "Transforming Drug Discovery: Generative Models and Electrostatic Complementarity," will focus on AI and automation in drug discovery. Gain Therapeutics specializes in developing next-generation allosteric therapies, with its lead candidate GT-02287 in Phase 1b trials for Parkinson's disease. The comp...
09-23 11:40
特朗普新招：一场“集资式晚宴”
（来源：华山穹剑） 9月4日，特朗普在装修一新的白宫玫瑰园举办晚宴，邀请的是全美国据称“最聪明的人”——20多位科技巨头，他们包括Meta的扎克伯格、苹果的库克...
09-07 20:51
派息除权日
|
每股总股息
| 派息日期 |
2025-12-22
|
0.08
|
2025-12-31
|
2025-11-17
|
0.08
|
2025-11-26
|
2025-10-24
|
0.08
|
2025-10-31
|
2025-09-22
|
0.08
|
2025-09-30
|
2025-08-20
|
0.08
|
2025-08-29
|
2025-07-21
|
0.08
|
2025-07-31
|
2025-06-20
|
0.08
|
2025-06-30
|
2025-06-04
|
0.54
|
2025-06-13
|
2025-05-21
|
0.08
|
2025-05-30
|
2025-04-21
|
0.08
|
2025-04-30
|
2025-03-19
|
0.08
|
2025-03-31
|
2025-02-19
|
0.08
|
2025-02-28
|
2025-01-24
|
0.08
|
2025-01-31
|
2024-12-20
|
0.08
|
2024-12-31
|
2024-11-20
|
0.08
|
2024-11-29
|
2024-10-22
|
0.08
|
2024-10-31
|
2024-10-04
|
0.70
|
2024-10-15
|
2024-09-20
|
0.08
|
2024-09-30
|
2024-08-21
|
0.08
|
2024-08-30
|
2024-07-22
|
0.08
|
2024-07-31
|
2024-06-18
|
0.08
|
2024-06-28
|
2024-05-16
|
0.08
|
2024-05-31
|
2024-04-18
|
0.08
|
2024-04-30
|
2024-03-20
|
0.08
|
2024-03-29
|
2024-02-20
|
0.08
|
2024-02-29
|
2024-01-22
|
0.08
|
2024-01-31
|
2023-12-15
|
0.08
|
2023-12-29
|
2023-12-04
|
0.88
|
2023-12-15
|
2023-11-17
|
0.08
|
2023-11-30
|
2023-11-06
|
0.12
|
2023-11-17
|
2023-10-19
|
0.08
|
2023-10-31
|
2023-09-20
|
0.08
|
2023-09-29
|
2023-09-06
|
0.12
|
2023-09-15
|
2023-08-22
|
0.08
|
2023-08-31
|
2023-07-20
|
0.08
|
2023-07-31
|
2023-06-20
|
0.08
|
2023-06-30
|
2023-06-02
|
0.12
|
2023-06-15
|
2023-05-22
|
0.08
|
2023-05-31
|
2023-04-20
|
0.08
|
2023-04-28
|
2023-03-16
|
0.08
|
2023-03-31
|
2023-03-02
|
0.24
|
2023-03-15
|
2023-02-16
|
0.08
|
2023-02-28
|
2023-01-19
|
0.08
|
2023-01-31
|
2022-12-19
|
0.08
|
2022-12-30
|
2022-12-05
|
0.12
|
2022-12-15
|
2022-11-17
|
0.08
|
2022-11-30
|
2022-10-20
|
0.08
|
2022-10-31
|
2022-09-21
|
0.08
|
2022-09-30
|
2022-08-22
|
0.08
|
2022-08-31
|
2022-07-21
|
0.08
|
2022-07-29
|
2022-06-21
|
0.08
|
2022-06-30
|
2022-06-03
|
0.12
|
2022-06-15
|
2022-05-19
|
0.08
|
2022-05-31
|
2022-04-21
|
0.08
|
2022-04-29
|
2022-03-22
|
0.08
|
2022-03-31
|
2022-02-17
|
0.08
|
2022-02-28
|
2022-02-03
|
0.12
|
2022-02-14
|
2022-01-20
|
0.08
|
2022-01-31
|
2021-12-22
|
0.08
|
2021-12-31
|
2021-12-06
|
0.09
|
2021-12-15
|
2021-11-18
|
0.08
|
2021-11-30
|
2021-10-21
|
0.08
|
2021-10-29
|
2021-09-21
|
0.07
|
2021-09-30
|
2021-09-02
|
0.03
|
2021-09-15
|
2021-08-20
|
0.07
|
2021-08-31
|
2021-07-22
|
0.07
|
2021-07-30
|
2021-06-17
|
0.07
|
2021-06-30
|
2021-06-07
|
0.06
|
2021-06-17
|
2021-05-18
|
0.07
|
2021-05-28
|
2021-04-22
|
0.07
|
2021-04-30
|
2021-03-17
|
0.07
|
2021-03-31
|
2021-02-16
|
0.07
|
2021-02-26
|
2021-01-21
|
0.07
|
2021-01-29
|
2020-12-22
|
0.07
|
2020-12-31
|
2020-11-19
|
0.07
|
2020-11-30
|
2020-10-22
|
0.07
|
2020-10-30
|
2020-09-22
|
0.07
|
2020-09-30
|
2020-08-21
|
0.07
|
2020-08-31
|
2020-07-23
|
0.07
|
2020-07-31
|
2020-06-18
|
0.07
|
2020-06-30
|
2020-06-05
|
0.09
|
2020-06-17
|
2020-05-18
|
0.07
|
2020-05-29
|
2020-04-23
|
0.07
|
2020-04-30
|
2020-03-19
|
0.07
|
2020-03-31
|
2020-02-18
|
0.07
|
2020-02-28
|
2020-01-23
|
0.07
|
2020-01-31
|
2019-12-18
|
0.07
|
2019-12-31
|
2019-12-02
|
0.09
|
2019-12-13
|
2019-11-18
|
0.07
|
2019-11-29
|
2019-10-21
|
0.07
|
2019-10-31
|
2019-09-16
|
0.07
|
2019-09-30
|
2019-09-03
|
0.03
|
2019-09-13
|
2019-08-19
|
0.07
|
2019-08-30
|
2019-07-19
|
0.07
|
2019-07-31
|
2019-06-18
|
0.07
|
2019-06-28
|
2019-06-04
|
0.09
|
2019-06-14
|
2019-05-21
|
0.07
|
2019-05-31
|
2019-04-18
|
0.07
|
2019-04-30
|
2019-03-19
|
0.07
|
2019-03-29
|
2019-02-19
|
0.07
|
2019-02-28
|
2019-01-17
|
0.07
|
2019-01-31
|
2018-12-19
|
0.07
|
2018-12-31
|
2018-12-06
|
0.06
|
2018-12-14
|
2018-11-19
|
0.07
|
2018-11-30
|
2018-10-18
|
0.07
|
2018-10-31
|
2018-09-18
|
0.07
|
2018-09-28
|
2018-08-20
|
0.07
|
2018-08-31
|
2018-07-19
|
0.07
|
2018-07-31
|
2018-06-19
|
0.07
|
2018-06-29
|
2018-06-05
|
0.06
|
2018-06-15
|
2018-05-21
|
0.07
|
2018-05-31
|
2018-04-19
|
0.07
|
2018-04-30
|
2018-03-19
|
0.06
|
2018-03-30
|
2018-02-15
|
0.06
|
2018-02-28
|
2018-01-19
|
0.06
|
2018-01-31
|
2017-12-18
|
0.06
|
2017-12-29
|
2017-12-04
|
0.06
|
2017-12-15
|
2017-11-17
|
0.06
|
2017-11-30
|
2017-10-19
|
0.06
|
2017-10-31
|
2017-09-19
|
0.06
|
2017-09-29
|
2017-08-17
|
0.06
|
2017-08-31
|
2017-07-19
|
0.06
|
2017-07-31
|
2017-06-19
|
0.06
|
2017-06-30
|
2017-06-01
|
0.06
|
2017-06-15
|
2017-05-17
|
0.06
|
2017-05-31
|
2017-04-19
|
0.06
|
2017-04-28
|
2017-03-20
|
0.06
|
2017-03-31
|
2017-02-14
|
0.06
|
2017-02-28
|
2017-01-18
|
0.06
|
2017-01-31
|
2016-12-16
|
0.06
|
2016-12-30
|
2016-11-15
|
0.06
|
2016-11-30
|
2016-10-19
|
0.06
|
2016-10-31
|
2016-09-19
|
0.06
|
2016-09-30
|
2016-08-18
|
0.06
|
2016-08-31
|
2016-07-20
|
0.06
|
2016-08-02
|
2016-06-15
|
0.06
|
2016-06-30
|
2016-05-17
|
0.06
|
2016-05-31
|
2016-04-20
|
0.06
|
2016-05-02
|
2016-03-17
|
0.06
|
2016-03-31
|
2016-02-16
|
0.06
|
2016-02-29
|
2016-01-20
|
0.06
|
2016-02-02
|
2015-12-16
|
0.06
|
2015-12-31
|
2015-11-13
|
0.06
|
2015-11-30
|
2015-10-22
|
0.06
|
2015-11-04
|
2015-09-17
|
0.06
|
2015-09-30
|
2015-08-18
|
0.06
|
2015-08-31
|
2015-07-22
|
0.06
|
2015-08-04
|
2015-06-17
|
0.06
|
2015-06-30
|
2015-05-15
|
0.06
|
2015-05-29
|
2015-04-22
|
0.06
|
2015-05-05
|
2015-03-18
|
0.06
|
2015-03-31
|
2015-02-13
|
0.06
|
2015-02-27
|
2015-01-21
|
0.06
|
2015-02-03
|
2014-12-17
|
0.11
|
2014-12-31
|
2014-11-13
|
0.06
|
2014-11-26
|
2014-10-20
|
0.06
|
2014-10-31
|
2014-09-17
|
0.06
|
2014-09-30
|
2014-08-18
|
0.06
|
2014-08-29
|
2014-07-23
|
0.06
|
2014-08-05
|
2014-06-17
|
0.06
|
2014-06-30
|
2014-05-16
|
0.06
|
2014-05-30
|
2014-04-16
|
0.06
|
2014-04-30
|
2014-03-13
|
0.06
|
2014-03-31
|
2014-02-14
|
0.06
|
2014-02-28
|
2014-01-17
|
0.06
|
2014-01-31
|
2013-12-12
|
0.06
|
2013-12-31
|
2013-11-14
|
0.05
|
2013-11-29
|
2013-11-12
|
0.06
|
2013-11-29
|
2013-10-18
|
0.06
|
2013-10-31
|
2013-09-16
|
0.05
|
2013-09-30
|
2013-08-19
|
0.05
|
2013-08-30
|
2013-07-17
|
0.05
|
2013-07-31
|
2013-06-17
|
0.05
|
2013-06-28
|
2013-05-16
|
0.05
|
2013-05-31
|
2013-04-18
|
0.05
|
2013-04-30
|
2013-03-13
|
0.05
|
2013-03-28
|
2013-02-13
|
0.05
|
2013-02-28
|
2013-01-16
|
0.05
|
2013-01-31
|
2012-12-17
|
0.05
|
2012-12-31
|
2012-11-15
|
0.05
|
2012-11-30
|
2012-10-18
|
0.05
|
2012-10-31
|
2012-09-17
|
0.05
|
2012-09-28
|
2012-08-20
|
0.05
|
2012-08-31
|
2012-07-18
|
0.05
|
2012-07-31
|
2012-06-18
|
0.05
|
2012-06-29
|
2012-05-16
|
0.05
|
2012-05-31
|
2012-04-18
|
0.05
|
2012-04-30
|
2012-03-20
|
0.08
|
2012-03-30
|
2012-02-16
|
0.05
|
2012-02-29
|
2012-01-19
|
0.05
|
2012-01-31
|
2011-12-19
|
0.05
|
2011-12-30
|
2011-11-15
|
0.05
|
2011-11-30
|
2011-10-19
|
0.05
|
2011-10-31
|
2011-09-20
|
0.05
|
2011-09-30
|
2011-08-17
|
0.05
|
2011-08-31
|
2011-07-20
|
0.05
|
2011-07-29
|
2011-06-16
|
0.05
|
2011-06-30
|
2011-05-18
|
0.05
|
2011-05-31
|
2011-04-19
|
0.05
|
2011-04-29
|
2011-03-17
|
0.04
|
2011-03-31
|
2011-02-16
|
0.04
|
2011-02-28
|
2011-01-19
|
0.04
|
2011-01-31
|
2010-12-21
|
0.04
|
2010-12-31
|
2010-11-17
|
0.04
|
2010-11-30
|
2010-10-19
|
0.04
|
2010-10-29
|
2010-09-20
|
0.04
|
2010-09-30
|
2010-08-19
|
0.04
|
2010-08-31
|
2010-07-20
|
0.04
|
2010-07-30
|
2010-06-18
|
0.04
|
2010-06-30
|
2010-05-18
|
0.04
|
2010-05-28
|
2010-04-20
|
0.04
|
2010-04-30
|
2010-03-19
|
0.04
|
2010-03-31
|
2010-02-16
|
0.04
|
2010-02-26
|
2010-01-19
|
0.04
|
2010-01-29
|
2009-12-18
|
0.04
|
2009-12-31
|
2009-11-17
|
0.04
|
2009-11-30
|
2009-10-20
|
0.04
|
2009-10-30
|
2009-09-18
|
0.04
|
2009-09-30
|
2009-08-19
|
0.04
|
2009-08-31
|
2009-07-21
|
0.04
|
2009-07-31
|
2009-06-18
|
0.04
|
2009-06-30
|
2009-05-18
|
0.04
|
2009-05-29
|
2009-04-23
|
0.04
|
2009-05-08
|
2009-03-19
|
0.08
|
2009-03-31
|
2009-02-17
|
0.08
|
2009-02-27
|
2009-01-20
|
0.08
|
2009-01-30
|
2008-12-18
|
0.08
|
2008-12-31
|
2008-11-17
|
0.08
|
2008-11-28
|
2008-10-21
|
0.08
|
2008-10-31
|
2008-09-18
|
0.08
|
2008-09-30
|
2008-08-19
|
0.08
|
2008-08-29
|
2008-07-21
|
0.08
|
2008-07-31
|
2008-06-18
|
0.08
|
2008-06-30
|
2008-05-19
|
0.08
|
2008-05-30
|
2008-04-18
|
0.08
|
2008-04-30
|
2008-03-18
|
0.08
|
2008-03-31
|
2008-02-19
|
0.08
|
2008-02-29
|
2008-01-18
|
0.08
|
2008-01-31
|
2007-12-18
|
0.08
|
2007-12-31
|
2007-11-19
|
0.08
|
2007-11-30
|
2007-10-19
|
0.08
|
2007-10-31
|
2007-09-18
|
0.08
|
2007-09-28
|
2007-08-21
|
0.08
|
2007-08-31
|
2007-07-19
|
0.08
|
2007-07-31
|
2007-06-19
|
0.08
|
2007-06-29
|
2007-05-18
|
0.08
|
2007-05-31
|
2007-04-18
|
0.08
|
2007-04-30
|
2007-03-20
|
0.08
|
2007-03-30
|
2007-02-15
|
0.08
|
2007-02-28
|
2007-01-19
|
0.08
|
2007-01-31
|
2006-12-18
|
0.07
|
2006-12-29
|
2006-11-17
|
0.07
|
2006-11-30
|
2006-10-19
|
0.07
|
2006-10-31
|
2006-09-19
|
0.07
|
2006-09-29
|
2006-08-21
|
0.07
|
2006-08-31
|
2006-07-19
|
0.07
|
2006-07-31
|
2006-06-20
|
0.07
|
2006-06-30
|
2006-05-18
|
0.07
|
2006-05-31
|
2006-04-18
|
0.07
|
2006-04-28
|
2006-03-21
|
0.07
|
2006-03-31
|
2006-02-15
|
0.07
|
2006-02-28
|
2006-01-17
|
0.07
|
2006-01-31
|
2005-12-19
|
0.04
|
2005-12-30
|
2005-11-17
|
0.04
|
2005-11-30
|
2005-10-19
|
0.04
|
2005-10-31
|
2005-09-20
|
0.02
|
2005-09-30
|
2005-08-19
|
0.02
|
2005-08-31
|
2005-07-19
|
0.02
|
2005-07-29
|
